BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

244 related articles for article (PubMed ID: 36450103)

  • 21. Bromodomain and extra-terminal motif (BET) inhibition is synthetic lethal with loss of SMAD4 in colorectal cancer cells via restoring the loss of MYC repression.
    Shi C; Yang EJ; Liu Y; Mou PK; Ren G; Shim JS
    Oncogene; 2021 Feb; 40(5):937-950. PubMed ID: 33293694
    [TBL] [Abstract][Full Text] [Related]  

  • 22. miR-34a mediates oxaliplatin resistance of colorectal cancer cells by inhibiting macroautophagy
    Sun C; Wang FJ; Zhang HG; Xu XZ; Jia RC; Yao L; Qiao PF
    World J Gastroenterol; 2017 Mar; 23(10):1816-1827. PubMed ID: 28348487
    [TBL] [Abstract][Full Text] [Related]  

  • 23. SMAD4-dependent barrier constrains prostate cancer growth and metastatic progression.
    Ding Z; Wu CJ; Chu GC; Xiao Y; Ho D; Zhang J; Perry SR; Labrot ES; Wu X; Lis R; Hoshida Y; Hiller D; Hu B; Jiang S; Zheng H; Stegh AH; Scott KL; Signoretti S; Bardeesy N; Wang YA; Hill DE; Golub TR; Stampfer MJ; Wong WH; Loda M; Mucci L; Chin L; DePinho RA
    Nature; 2011 Feb; 470(7333):269-73. PubMed ID: 21289624
    [TBL] [Abstract][Full Text] [Related]  

  • 24. TGFβ-induced SMAD4-dependent Apoptosis Proceeded by EMT in CRC.
    Siraj AK; Pratheeshkumar P; Divya SP; Parvathareddy SK; Bu R; Masoodi T; Kong Y; Thangavel S; Al-Sanea N; Ashari LH; Abduljabbar A; Al-Homoud S; Al-Dayel F; Al-Kuraya KS
    Mol Cancer Ther; 2019 Jul; 18(7):1312-1322. PubMed ID: 31053577
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Preliminary Study of the Role F-Box Protein 32 (FBXO32) in Colorectal Neoplasms Through the Transforming Growth Factor beta (TGF-β)/Smad4 Signalling Pathway.
    Yuan X; Zhang Z; Jiang K; Wang X; Li Y
    Med Sci Monit; 2018 Feb; 24():1080-1088. PubMed ID: 29465067
    [TBL] [Abstract][Full Text] [Related]  

  • 26. TRIM47 is up-regulated in colorectal cancer, promoting ubiquitination and degradation of SMAD4.
    Liang Q; Tang C; Tang M; Zhang Q; Gao Y; Ge Z
    J Exp Clin Cancer Res; 2019 Apr; 38(1):159. PubMed ID: 30979374
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Loss of SMAD4 Promotes Colorectal Cancer Progression by Recruiting Tumor-Associated Neutrophils via the CXCL1/8-CXCR2 Axis.
    Ogawa R; Yamamoto T; Hirai H; Hanada K; Kiyasu Y; Nishikawa G; Mizuno R; Inamoto S; Itatani Y; Sakai Y; Kawada K
    Clin Cancer Res; 2019 May; 25(9):2887-2899. PubMed ID: 30705034
    [TBL] [Abstract][Full Text] [Related]  

  • 28. AMBRA1 Promotes TGFβ Signaling via Nonproteolytic Polyubiquitylation of Smad4.
    Liu J; Yuan B; Cao J; Luo H; Gu S; Zhang M; Ding R; Zhang L; Zhou F; Hung MC; Xu P; Lin X; Jin J; Feng XH
    Cancer Res; 2021 Oct; 81(19):5007-5020. PubMed ID: 34362797
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Uncoupled responses of Smad4-deficient cancer cells to TNFalpha result in secretion of monomeric laminin-gamma2.
    Zboralski D; Warscheid B; Klein-Scory S; Malas MB; Becker H; Böckmann M; Meyer HE; Schmiegel W; Simon-Assmann P; Schwarte-Waldhoff I
    Mol Cancer; 2010 Mar; 9(1):65. PubMed ID: 20307265
    [TBL] [Abstract][Full Text] [Related]  

  • 30. TGFβ and the Tumor Microenvironment in Colorectal Cancer.
    Waldner MJ; Neurath MF
    Cells; 2023 Apr; 12(8):. PubMed ID: 37190048
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Smad4 regulates claudin-1 expression in a transforming growth factor-beta-independent manner in colon cancer cells.
    Shiou SR; Singh AB; Moorthy K; Datta PK; Washington MK; Beauchamp RD; Dhawan P
    Cancer Res; 2007 Feb; 67(4):1571-9. PubMed ID: 17308096
    [TBL] [Abstract][Full Text] [Related]  

  • 32. A Transition Zone Showing Highly Discontinuous or Alternating Levels of Stem Cell and Proliferation Markers Characterizes the Development of PTEN-Haploinsufficient Colorectal Cancer.
    Arvai KJ; Hsu YH; Lee LA; Jones D
    PLoS One; 2015; 10(6):e0131108. PubMed ID: 26098881
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Bidirectional tumor/stroma crosstalk promotes metastasis in mesenchymal colorectal cancer.
    Ouahoud S; Voorneveld PW; van der Burg LRA; de Jonge-Muller ESM; Schoonderwoerd MJA; Paauwe M; de Vos T; de Wit S; van Pelt GW; Mesker WE; Hawinkels LJAC; Hardwick JCH
    Oncogene; 2020 Mar; 39(12):2453-2466. PubMed ID: 31974473
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Downregulated USP3 mRNA functions as a competitive endogenous RNA of SMAD4 by sponging miR-224 and promotes metastasis in colorectal cancer.
    Wang Z; Yang J; Di J; Cui M; Xing J; Wu F; Wu W; Yang H; Zhang C; Yao Z; Zhang N; Jiang B; Su X
    Sci Rep; 2017 Jun; 7(1):4281. PubMed ID: 28655924
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The role of TGF-β/SMAD4 signaling in cancer.
    Zhao M; Mishra L; Deng CX
    Int J Biol Sci; 2018; 14(2):111-123. PubMed ID: 29483830
    [TBL] [Abstract][Full Text] [Related]  

  • 36. GATA3 transcription factor abrogates Smad4 transcription factor-mediated fascin overexpression, invadopodium formation, and breast cancer cell invasion.
    Sun J; He H; Pillai S; Xiong Y; Challa S; Xu L; Chellappan S; Yang S
    J Biol Chem; 2013 Dec; 288(52):36971-82. PubMed ID: 24235142
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Deubiquitinating enzyme USP10 promotes hepatocellular carcinoma metastasis through deubiquitinating and stabilizing Smad4 protein.
    Yuan T; Chen Z; Yan F; Qian M; Luo H; Ye S; Cao J; Ying M; Dai X; Gai R; Yang B; He Q; Zhu H
    Mol Oncol; 2020 Jan; 14(1):197-210. PubMed ID: 31721429
    [TBL] [Abstract][Full Text] [Related]  

  • 38. SMAD4 is critical in suppression of BRAF-V600E serrated tumorigenesis.
    Tong K; Kothari OA; Haro KS; Panda A; Bandari MM; Carrick JN; Hur JJ; Zhang L; Chan CS; Xing J; Gatza ML; Ganesan S; Verzi MP
    Oncogene; 2021 Oct; 40(41):6034-6048. PubMed ID: 34453124
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Aberrant Phosphorylation of SMAD4 Thr277-Mediated USP9x-SMAD4 Interaction by Free Fatty Acids Promotes Breast Cancer Metastasis.
    Wu Y; Yu X; Yi X; Wu K; Dwabe S; Atefi M; Elshimali Y; Kemp KT; Bhat K; Haro J; Sarkissyan M; Vadgama JV
    Cancer Res; 2017 Mar; 77(6):1383-1394. PubMed ID: 28115363
    [TBL] [Abstract][Full Text] [Related]  

  • 40. SMAD4 suppresses AURKA-induced metastatic phenotypes via degradation of AURKA in a TGFβ-independent manner.
    Jia L; Lee HS; Wu CF; Kundu J; Park SG; Kim RN; Wang LH; Erkin ÖC; Choi JS; Chae SW; Yang HB; Choi YL; Shin YK
    Mol Cancer Res; 2014 Dec; 12(12):1779-95. PubMed ID: 25061104
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.